Senna S Tablet
NDC Package 36800-783-12
Package Information
Senna S (docusate sodium, sennosides) tablets is a medication used to treat constipation. This formulation utilizes a tablet delivery system. Marketed by Top Care (topco Associates Llc), this product is identified by NDC 36800-783 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
- RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 36800 - Top Care (topco Associates Llc)
- 36800-783 - Senna S
- 36800-783-12 - 1 BOTTLE, PLASTIC in 1 BOX / 120 TABLET in 1 BOTTLE, PLASTIC
- 36800-783 - Senna S
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (36800-783). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 36800-783-12 identifies a specific commercial package of 1 bottle, plastic in 1 box / 120 tablet in 1 bottle, plastic of Senna S, a human over the counter drug labeled by Top Care (topco Associates Llc). This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Top Care (topco Associates Llc) on July 31, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to treat constipation. It contains 2 medications: sennosides and docusate. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which helps to cause movement of the intestines. Docusate is known as a stool softener. It helps increase the amount of water in the stool, making it softer and easier to pass.
How is this Top Care (topco Associates Llc) product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 36800078312. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.